arrow
G

Gerard C.M. Linssen

zorggroep twente
H指数:41
被引数:7,019

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ten-year survival after stenting the proximal left anterior descending coronary artery with new-generation drug-eluting stents

使用新一代药物洗脱支架对近端左前降支冠状动脉进行支架植入术后的十年生存率

2026-09-160
OAAI
Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial

低剂量地高辛在射血分数降低或轻度降低的心力衰竭患者中的应用:一项随机对照试验

2026-05-100
OAAI
Complex all-comers and patients with diabetes and prediabetes treated with Xience Sierra everolimus-eluting stents: COASTLINE high-risk
2025-11-010
OA
Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

心力衰竭伴射血分数降低的指南推荐药物治疗真实世界实施:对预后和左心室射血分数的影响。TITRATE-HF研究主要结果

2025-08-140
PREAI
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
2024-10-2443
PRE
Serial cardiac biomarkers, pulmonary artery pressures and traditional parameters of fluid status in relation to prognosis in patients with chronic heart failure: Design and rationale of the BioMEMS study
2024-06-022
OAAI
Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study

新的,慢性的和恶化的心力衰竭患者的当代指南指导的药物治疗: 来自TITRATE-HF研究的第一个数据

2024-05-123
OA
Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial
2024-05-113
OAAI
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial

射血分数轻度降低或保留的心力衰竭患者的基线特征: finearts-hf试验

2024-05-1110
OAAI
Guideline implementation, drug sequencing, and quality of care in heart failure: design and rationale of TITRATE-HF
2023-12-085
OA
Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease
2023-03-014
OAAI